期刊
JOURNAL OF MEDICAL VIROLOGY
卷 92, 期 7, 页码 726-730出版社
WILEY
DOI: 10.1002/jmv.25785
关键词
acute respiratory distress syndrome (ARDS); angiotensin-converting enzyme 2 (ACE2); coronavirus disease 2019 (COVID-19); renin-angiotensin system (RAS); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
类别
资金
- National Natural Science Foundation of China [81870417]
- 13th Five-Year National Science and Technology Major Project [2017ZX10203202, 2018ZX10302206-001-007]
This article reviews the correlation between angiotensin-converting enzyme 2 (ACE2) and severe risk factors for coronavirus disease 2019 (COVID-19) and the possible mechanisms. ACE2 is a crucial component of the renin-angiotensin system (RAS). The classical RAS ACE-Ang II-AT1R regulatory axis and the ACE2-Ang 1-7-MasR counter-regulatory axis play an essential role in maintaining homeostasis in humans. ACE2 is widely distributed in the heart, kidneys, lungs, and testes. ACE2 antagonizes the activation of the classical RAS system and protects against organ damage, protecting against hypertension, diabetes, and cardiovascular disease. Similar to SARS-CoV, SARS-CoV-2 also uses the ACE2 receptor to invade human alveolar epithelial cells. Acute respiratory distress syndrome (ARDS) is a clinical high-mortality disease, and ACE2 has a protective effect on this type of acute lung injury. Current research shows that the poor prognosis of patients with COVID-19 is related to factors such as sex (male), age (>60 years), underlying diseases (hypertension, diabetes, and cardiovascular disease), secondary ARDS, and other relevant factors. Because of these protective effects of ACE2 on chronic underlying diseases and ARDS, the development of spike protein-based vaccine and drugs enhancing ACE2 activity may become one of the most promising approaches for the treatment of COVID-19 in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据